TrinamiX, a subsidiary of BASF, has filed a lawsuit accusing Apple of infringing on seven of its patents through Apple’s current Face ID implementation. The complaint, lodged in the U.S. District Court for the Western District of Texas, seeks damages, attorneys’ fees, and an injunction preventing use, sales, or imports of the allegedly violating devices.
What patents are at issue?
The patents in question fall into two groups. The first relates to optical skin detection during facial authentication—designed to prevent spoofing via photographs, masks, or other non-skin materials. The second group concerns detecting material properties of a surface to differentiate real human skin from falsified faces.
TrinamiX says its method involves projecting a light pattern onto a face and analyzing the returned light along with 3D depth information to identify human skin—something it claims is absent in presentations like photos or masks. The company asserts this capability addresses earlier Face ID vulnerabilities, such as those discovered via special 3-D masks aimed at fooling authentication.
Which Apple products are named?
The suit names several iPhone and iPad models for alleged infringement. On the iPhone side: iPhone 15, 15 Plus, 15 Pro, 15 Pro Max; all versions of iPhone 16 (including the “e,” Plus, and Pro models); iPhone 17 line including Pro and “e” variants; and iPhone Air. For iPads: the 11-inch iPad Pro (4th gen), 12.9-inch iPad Pro (6th gen), and certain 11- and 13-inch models under the M4 and M5 series. The complaint also notes “other infringing iPhone and iPad models,” though these models are not specifically listed.
The suit requests that a jury find Apple liable for infringement, award damages, and bar Apple from manufacturing, using, selling, offering for sale, or importing the accused devices within the U.S.
Background & timing
TrinamiX, originally a startup and now part of BASF, specializes in advanced sensing: biometric imaging, 3D vision, and near-infrared spectroscopy for both consumer and industrial uses. The patent‐infringed technologies are tied to their biometric and imaging expertise.
The case hinges on newer Face ID implementations. TrinamiX alleges that recent versions of Face ID—specifically in the listed iPhone and iPad models—utilize techniques covered by TrinamiX’s patents. The complaint was officially filed on September 3, 2026, and includes a request for a jury trial in the Western District of Texas.
What this means going forward
If the court sides with TrinamiX, Apple could face an order stopping sales of its Face ID-equipped devices in the U.S. and owing financial penalties. Apple may also need to modify its Face ID tech—or license the patents to avoid blockage.
Meanwhile, Apple’s legal strategy may hinge on arguments that its Face ID design is either non-infringing, that TrinamiX’s patents are invalid, or that prior art already negates them. The lawsuit may ignite a technical showdown over facial recognition, liveness detection, and biometric security standards more broadly.
Analytical perspective: This suit marks another flashpoint in the ongoing clash between tech giants and patent holders in the biometrics space. As consumer demand for secure facial authentication grows, so do the stakes tied to detecting the difference between real human tissue and spoof materials. The outcome could reshape how manufacturers implement anti-spoofing safeguards. For Apple, a ruling against it may mean costly redesigns or licensing fees; for TrinamiX, it could validate years of investment in skin detection research. Watch closely how courts interpret these patents and what that spells for Face ID’s future evolution.
